Conversely, aberrant methylation of the CDH4 gene promoter suggests that CDH4 may also function as a tumor suppressor gene in human nasopharyngeal, colorectal, and gastric cancer [14, 34]. This evidence concerns the gene CDH4 and neoplasm.